Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

HRTX Stock Annual Cash Flow. Download in Excel

Heron Therapeutics Inc. logo

Heron Therapeutics Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

1.58
 
USD
  
0.05
  
(3.27%)
Previous close: 1.53  Open: 1.48  Bid: 1.35  Ask: 1.62
52 week range    
1.04   
   3.93
Mkt Cap: 251 M  Avg Vol (90 Days): 2,883,902
Peers   
DRRX / 
ALKS / 
PCRX / 
NKTR / 
LGND / 
Last updated: Sunday 22nd December 2024

Stock Rankings

45
MarketXLS Rank
40
Value
46
Technical
50
Quality
How are these ranks calculated?
Search for a stock

Financials

HRTX Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in inventories-5 M-5 M-29 M14 M-17 M-6 M-6 M12 M
(Increase) Decrease in other current liabilities1 M2 M
(Increase) Decrease in payables1 M751000.04 M12 M-2 M-14 M-2 M3 M-578000.015000.0
(Increase) Decrease in receivables-2 M-40 M-23 M25 M-2 M6 M-17 M-8 M
Amortization of intangibles89000.0274000.0
AssetImpairmentCharge905000.072000.0107000.0847000.0478000.0209000.0617000.0
CapitalExpenditureReported1 M1 M3 M3 M9 M7 M7 M3 M2 M2 M
Cash at beginning of period72 M73 M75 M13 M145 M32 M72 M105 M91 M15 M
Cash at end of period73 M75 M13 M145 M176 M72 M105 M91 M15 M29 M
Cash flow-60 M-79 M-134 M-170 M-192 M-125 M-185 M-203 M-147 M-59 M
CashFlowFromContinuingInvestingActivities-1 M-57 M15 M8 M-279 M-22 M209 M33 M-3 M18 M
ChangeInAccountPayable1 M751000.04 M12 M-2 M-14 M-2 M3 M-578000.015000.0
ChangeInAccruedExpense3 M2 M2 M11 M15 M5 M-7 M-5 M13 M3 M
ChangeInPayablesAndAccruedExpense4 M2 M6 M23 M13 M-10 M-9 M-2 M12 M3 M
ChangeInPrepaidAssets-419000.0-2 M-338000.03000.0-7 M-12 M1 M-8 M1 M15 M
ChangeInWorkingCapital4 M-141000.0-543000.0-20 M-46 M17 M-27 M-10 M-9 M23 M
ChangesInAccountReceivables-2 M-40 M-23 M25 M-2 M6 M-17 M-8 M
Depreciation578000.0734000.01 M2 M2 M2 M3 M3 M3 M3 M
Depreciation unreconciled1 M1 M2 M2 M-1 M-680000.04 M4 M2 M2 M
DepreciationAndAmortization1 M1 M2 M2 M-1 M-680000.03 M3 M3 M3 M
FinancingCashFlow62 M138 M57 M294 M502 M186 M9 M156 M75 M54 M
Free cash flow-62 M-79 M-137 M-173 M-201 M-132 M-192 M-206 M-149 M-60 M
GainLossOnInvestmentSecurities-8000.0
GainLossOnSaleOfPPE17000.0-118000.09000.039000.029000.062000.0822000.074000.010000.0
InterestPaidSupplementalData2 M3 M1 M1 M2 M3 M
Issuance of capital stock59 M128 M306 M363 M162 M7 M5 M75 M30 M
Issuance of debt50 M-25 M
IssuanceOfCapitalStock59 M128 M306 M363 M162 M7 M5 M75 M30 M
IssuanceOfDebt50 M-25 M-25 M149 M24 M
Net cash from financing activities62 M138 M57 M294 M502 M186 M9 M156 M75 M54 M
Net cash from investing activities-1 M-57 M15 M8 M-279 M-22 M209 M33 M-3 M18 M
Net cash from operating activities-60 M-79 M-134 M-170 M-192 M-125 M-185 M-203 M-147 M-59 M
Net change in cash & cash equivalents388000.03 M-62 M131 M32 M40 M33 M-15 M-75 M13 M
Net income from continuing operations-76 M-98 M-173 M-197 M-179 M-205 M-227 M-221 M-182 M-111 M
NetCommonStockIssuance59 M128 M306 M363 M162 M7 M5 M75 M30 M
NetInvestmentPropertiesPurchaseAndSale-56 M18 M10 M-269 M-15 M216 M36 M-2 M20 M
NetInvestmentPurchaseAndSale-56 M18 M10 M-269 M-15 M216 M36 M-2 M20 M
NetIssuancePaymentsOfDebt50 M-25 M-25 M149 M24 M
NetLongTermDebtIssuance-25 M-25 M149 M24 M
NetPPEPurchaseAndSale-1 M-845000.0-3 M-2 M-9 M-7 M-7 M-3 M-2 M-2 M
Operating (gains) losses182000.02 M4 M485000.05 M2 M-2 M2 M-2 M-4 M
Other financing charges net145 M26000.05 M-2 M-903000.0
Other non-cash items11 M16 M34 M44 M30 M62 M66 M21 M44 M31 M
PensionAndEmployeeBenefitExpense165000.02 M4 M446000.05 M2 M-2 M2 M-2 M-4 M
ProceedsFromIssuanceOfWarrants1000.03000.01000.0
ProceedsFromStockOptionExercised3 M10 M7 M12 M19 M24 M2 M2 M1 M904000.0
Purchase of Float term investments-56 M-43 M-122 M-497 M-477 M-134 M-129 M-146 M-88 M
Purchase of property plant & equipment-1 M-845000.0-3 M-2 M-9 M-7 M-7 M-3 M-2 M-2 M
Purchase of short term investments149 M24 M
PurchaseOfInvestment-56 M-43 M-122 M-497 M-477 M-134 M-129 M-146 M-88 M
PurchaseOfPPE-1 M-1 M-3 M-3 M-9 M-7 M-7 M-3 M-2 M-2 M
Repayment of debt-25 M-25 M
RepaymentOfDebt-25 M-25 M
Revenue per share573000.0713000.0963000.0495000.0-3 M-3 M2 M1 M-534000.0-1 M
Sale of short term investments61 M132 M228 M462 M350 M165 M144 M107 M
SaleOfInvestment61 M132 M228 M462 M350 M165 M144 M107 M
SaleOfPPE241000.078000.025000.032000.0227000.013000.0
ShortTermDebtIssuance50 M
ShortTermDebtPayments-25 M
StockBasedCompensation8 M14 M26 M31 M33 M51 M50 M47 M43 M33 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University